Forbes -
2 May 2014 19:00
In trading on Friday, biotechnology shares were relative laggards, down on the day by about 1.6%. Helping drag down the group were shares of Endocyte (ECYT), off about 62% and shares of Immunomedics (IMMU) down about 20.8% on the day.
Share this Article
Comment on this Article
Please to comment